Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism

Daniel Lindqvist1,2, Inga Prokopenko3, Elisabet Londos4,5

  • 1Division of Psychiatry, Department of Clinical Sciences, Lund University, Lund, Sweden.

Abstract

Insights

TOMM40 gene variants do not appear to independently influence Parkinson's disease with dementia (PDD) or Dementia with Lewy bodies (DLB). The observed associations are primarily driven by the APOE-ɛ4 allele, a known risk factor for dementia.

Area of Science:

  • Neuroscience
  • Genetics
  • Mitochondrial Biology

Background:

  • Mitochondrial dysfunction is a key factor in Parkinson's disease (PD) pathology.
  • Investigating genetic variants like TOMM40 is crucial for understanding PD subtypes.

Purpose of the Study:

  • To examine the association of Translocase of the Outer Mitochondrial Membrane 40 homolog (TOMM40) variants with PD without dementia (PDND), PD with dementia (PDD), and Dementia with Lewy bodies (DLB).

Main Methods:

  • Genotyping of the TOMM40 poly-T repeat (short, long, very long alleles) in 248 individuals (92 PDND, 55 PDD, 101 DLB).
  • Analysis using a log-additive genetic model, adjusting for age, sex, and APOEɛ4 status.
  • Assessment of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD): Aβ42 and Tau.

Main Results:

  • PDD/DLB status and abnormal CSF AD biomarkers (Aβ42, Aβ42/Tau ratio) correlated with APOEɛ4 and the long (L) TOMM40 allele.
  • The very long (VL) TOMM40 allele was less common in PDD/DLB patients.
  • After adjusting for APOEɛ4, TOMM40 L and VL alleles showed no significant association with dementia or CSF biomarkers. However, the short (S) allele showed a potential association with PDD/DLB and abnormal CSF Aβ42/Tau ratio, which did not withstand multiple comparison adjustments.

Conclusions:

  • TOMM40 poly-T repeat variants do not appear to independently impact PDD and DLB pathology.
  • The observed associations between TOMM40 variants and dementia are likely influenced by the APOEɛ4 allele.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
676
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.7K